Literature DB >> 22941356

Chronic inflammatory demyelinating polyradiculoneuropathy associated intracranial hypertension.

Ayca Altinkaya, Baris Topcular, Nazan Karagoz Sakalli, Demet Yandim Kuscu, Dursun Kirbas.   

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired immune-mediated demyelinating neuropathy. In this report, we detail the course of a 58-year-old male patient who had headache and double vision followed by progressive paresthesia and difficulty in walking. The patient had bilateral papilledema and mild leg weakness, absent ankle jerks and loss of sensation in distal parts of his lower and upper extremities. His electromyography (EMG) was concordant with CIDP and lumbar puncture revealed high opening pressure. The polyradiculoneuropathy as well as the papilledema and elevated cerebrospinal fluid (CSF) pressure improved under steroids. The improvement in intracranial hypertension (IHT) and papilledema under steroid treatment suggests that the IHT in this patient might be associated with CIDP.

Entities:  

Mesh:

Year:  2012        PMID: 22941356     DOI: 10.1007/s10072-012-1179-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Optic nerve sheath fenestration for intracranial hypertension associated with chronic inflammatory demyelinating polyneuropathy.

Authors:  Shery Thomas; Jennifer Tan; Mark Lawden; Raghavan Sampath
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-07       Impact factor: 1.746

2.  Intracranial hypertension with polyradiculopathy--early CSF diversion to optimize neurological recovery.

Authors:  Sapna Erat Sreedharan; Pournamy Sarathchandran; Girish Menon; Jayakrishnan Chellenton; P N Sylaja
Journal:  Br J Neurosurg       Date:  2012-03-26       Impact factor: 1.596

3.  Chronic inflammatory demyelinating polyneuropathy presenting with headache and papilledema.

Authors:  K E Morrison; P T Davies
Journal:  Headache       Date:  1999-04       Impact factor: 5.887

Review 4.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

5.  Normal cerebrospinal fluid protein, increased intracranial pressure, and the Guillain-Barré syndrome.

Authors:  R L Sullivan; A G Reeves
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

6.  Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses.

Authors:  G Midroni; P J Dyck
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

7.  Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Min-Suk Yoon; Andrew Chan; Ralf Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.